Stimuli-responsive liposomal nanoformulations in cancer therapy: Pre-clinical & clinical approaches
Stimuli-responsive liposomal nanoformulations in cancer therapy: Pre-clinical & clinical approaches is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Stimuli-responsive liposomal nanoformulations in cancer therapy: Pre-clinical & clinical approaches have?
Stimuli-responsive liposomal nanoformulations in cancer therapy: Pre-clinical & clinical approaches has 208 citations in the OpenAlex counts ScholarIQ stores.
When was Stimuli-responsive liposomal nanoformulations in cancer therapy: Pre-clinical & clinical approaches published?
Stimuli-responsive liposomal nanoformulations in cancer therapy: Pre-clinical & clinical approaches has 2022 year in the ScholarIQ index.
What is the open-access status of Stimuli-responsive liposomal nanoformulations in cancer therapy: Pre-clinical & clinical approaches?
Stimuli-responsive liposomal nanoformulations in cancer therapy: Pre-clinical & clinical approaches has hybrid oa status in the ScholarIQ index.
What is the DOI of Stimuli-responsive liposomal nanoformulations in cancer therapy: Pre-clinical & clinical approaches?
The DOI for Stimuli-responsive liposomal nanoformulations in cancer therapy: Pre-clinical & clinical approaches is on the source record.
What is the PMID of Stimuli-responsive liposomal nanoformulations in cancer therapy: Pre-clinical & clinical approaches?
The PMID for Stimuli-responsive liposomal nanoformulations in cancer therapy: Pre-clinical & clinical approaches is on the source record.
What is the OpenAlex record for Stimuli-responsive liposomal nanoformulations in cancer therapy: Pre-clinical & clinical approaches?
The OpenAlex for Stimuli-responsive liposomal nanoformulations in cancer therapy: Pre-clinical & clinical approaches is on the source record.